alanine has been researched along with sq 28603 in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 34 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cernacek, P; Farber, D; Legault, L; Levy, M; Maher, E | 1 |
Abboa-Offei, BE; Asaad, MM; Fennell, S; Rogers, WL; Rovnyak, PL; Seymour, AA | 1 |
Bennett, T; Gardiner, SM; Kemp, PA | 1 |
Abassi, ZA; Hunsberger, S; Keiser, HR; Klein, H; Tate, J; Trachewsky, D | 1 |
Gardner, D; Humphreys, MH; Qiu, CB; Valentin, JP; Wiedemann, E | 1 |
Burnett, JC; Margulies, KB; McKinley, LJ; Perrella, MA | 1 |
Abboa-Offei, B; Asaad, MM; Rogers, WL; Seymour, AA | 1 |
Asaad, MM; Fennell, SA; Kratunis, VJ; Little, DK; Norman, JA; Rogers, WL; Seymour, AA | 1 |
Asaad, MM; Gabel, RA; Harvey, CM; Rogers, WL; Trippodo, NC | 1 |
Abboa-Offei, B; Asaad, MM; Delaney, NG; Di Donato, G; Fennell, SA; Hunt, JT; Kratunis, VJ; Little, DK; Norman, JA; Seymour, AA | 1 |
Cohen, RB; Dickinson, KE; Hedberg, A; Liu, EC; Tymiak, AA; Webb, ML | 1 |
Burnett, JC; Cavero, PG; Delaney, NG; Margulies, KB; Seymour, AA | 1 |
Asaad, MM; Rogers, WL; Seymour, AA; Sheldon, JH; Smith, PL | 1 |
Asaad, MM; Dorso, CR; Moreland, SM | 1 |
Bird, JE; Waldron, TL | 1 |
Abboa-Offei, BE; Asaad, MM; Mathers, PD; Rogers, WL; Seymour, AA; Smith, PL | 1 |
Abassi, ZA; Golomb, E; Keiser, HR; Kotob, S; Pieruzzi, F | 1 |
Fox, M; Panchal, BC; Trippodo, NC | 1 |
Abboa-Offei, B; Asaad, MM; Rogers, WL; Seymour, AA; Smith, PL | 1 |
Asaad, M; Rogers, WL; Seymour, AA; Sheldon, JH; Smith, PL | 1 |
Asaad, MM; Cheung, HS; Fennell, SA; Lanoce, VM; Rogers, WL; Seymour, AA | 1 |
Asaad, MM; Dorso, CR; Fox, M; Natarajan, V; Panchal, BC; Trippodo, NC | 1 |
Asaad, MM; Fennell, SA; Langenbacher, KM; Lanoce, VM; Rogers, WL; Seymour, AA | 1 |
Abassi, ZA; Bridenbaugh, R; Golomb, E; Keiser, HR | 1 |
Bralet, J; Lecomte, JM; Marie, C; Mossiat, C; Schwartz, JC | 1 |
Allen, GT; Powell, JR; Tesfamariam, B | 1 |
Abboa-Offei, BE; Asaad, MM; Dorso, CR; Rogers, WL; Seymour, AA; Smith, PL | 1 |
Dietz, R; Höhnel, K; Luft, FC; Scheuermann, M; Willenbrock, R | 1 |
D'Orléans-Juste, P; Fournier, A; Lebel, N; Sirois, P | 1 |
Chakir, M; D'Orléans-Juste, P; Plante, GE | 1 |
Abboa-Offei, BE; Asaad, MM; Mathers, PD; Seymour, AA; Weber, H | 1 |
Bralet, J; Gros, C; Marie, C; Monteil, T; Mossiat, C | 1 |
Dietz, R; Scheuermann, M; Willenbrock, R | 1 |
Blumberg, S; Fudim, E; Gurbanov, K; Kaballa, A; Shuranyi, E; Winaver, J | 1 |
1 review(s) available for alanine and sq 28603
Article | Year |
---|---|
Potentiation of natriuretic peptides by neutral endopeptidase inhibitors.
Topics: Alanine; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Heart Failure; Hemodynamics; Hypertension; Neprilysin | 1995 |
33 other study(ies) available for alanine and sq 28603
Article | Year |
---|---|
Renal tubular responsiveness to atrial natriuretic peptide in sodium-retaining chronic caval dogs. A possible role for kinins and luminal actions of the peptide.
Topics: Alanine; Animals; Ascites; Atrial Natriuretic Factor; Chronic Disease; Cyclic GMP; Dogs; Female; Kidney Tubules; Kinins; Male; Neprilysin; Protease Inhibitors; Receptors, Bradykinin; Receptors, Neurotransmitter; Sodium | 1992 |
Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
Topics: Alanine; Animals; Atrial Natriuretic Factor; Brain; Diuresis; Drug Synergism; Female; Macaca fascicularis; Male; Natriuretic Peptide, Brain; Neprilysin; Nerve Tissue Proteins; Rats; Rats, Inbred SHR; Sodium; Species Specificity | 1992 |
Effects of the neutral endopeptidase inhibitor, SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or proendothelin-1 [1-38] in conscious rats.
Topics: Alanine; Angiotensin I; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Endothelin-1; Endothelins; Heart Rate; Injections, Intravenous; Male; Neprilysin; Protein Precursors; Rats | 1992 |
Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition.
Topics: Alanine; Animals; Atrial Natriuretic Factor; Male; Natriuresis; Neprilysin; Peptide Fragments; Rats; Rats, Inbred Strains; Receptors, Atrial Natriuretic Factor | 1992 |
Inhibition of neutral endopeptidase amplifies the effects of endogenous atrial natriuretic peptide on blood pressure and fluid partition.
Topics: Alanine; Animals; Atrial Natriuretic Factor; Blood Pressure; Blood Proteins; Blood Volume; Hematocrit; Infusions, Intravenous; Male; Neprilysin; Osmolar Concentration; Rats; Rats, Inbred Strains | 1992 |
Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.
Topics: Alanine; Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Dogs; Heart Failure; Hemodynamics; Kidney; Male; Neprilysin; Sodium | 1991 |
Evaluation of SQ 28,603, an inhibitor of neutral endopeptidase, in conscious monkeys.
Topics: Alanine; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Diuresis; Diuretics; Female; Hemodynamics; Kidney; Macaca fascicularis; Natriuresis; Neprilysin; Peptide Fragments; Sodium | 1991 |
Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase.
Topics: Alanine; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Cyclic GMP; Desoxycorticosterone; Diuresis; Hypertension; Infusions, Intravenous; Injections, Intravenous; Kidney; Male; Natriuresis; Neprilysin; Protease Inhibitors; Rats; Rats, Inbred Strains; Sodium Chloride | 1991 |
Heart failure augments the cardiovascular and renal effects of neutral endopeptidase inhibition in rats.
Topics: Alanine; Animals; Blood Pressure; Body Weight; Central Venous Pressure; Heart Failure; Heart Rate; Hemodynamics; Kidney; Male; Myocardial Infarction; Neprilysin; Protease Inhibitors; Rats; Rats, Inbred Strains | 1991 |
Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
Topics: Alanine; Animals; Atrial Natriuretic Factor; Blood Pressure; Desoxycorticosterone; Hypertension; Male; Neprilysin; Peptide Fragments; Rats; Rats, Inbred Strains | 1991 |
Vascular A10 cell membranes contain an endothelin metabolizing neutral endopeptidase.
Topics: Alanine; Animals; Aorta; Cell Line; Cell Membrane; Endothelins; Glycopeptides; Kidney; Kinetics; Microvilli; Muscle, Smooth, Vascular; Neprilysin; Rats; Thiorphan | 1991 |
Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor.
Topics: Alanine; Animals; Atrial Natriuretic Factor; Dogs; Glomerular Filtration Rate; Kidney; Natriuresis; Neprilysin; Renal Circulation | 1990 |
Atrial natriuretic peptide in chronically hypertensive dogs.
Topics: Alanine; Animals; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Diuretics; Dogs; Female; Humans; Hypertension, Renovascular; Injections, Intravenous; Kidney; Male; Neprilysin; Peptide Fragments | 1995 |
Effects of neutral endopeptidase inhibition on the clearance of exogenously administered endothelin in Sprague-Dawley rats.
Topics: Alanine; Animals; Atrial Natriuretic Factor; Cyclic GMP; Endothelins; Humans; Metabolic Clearance Rate; Neprilysin; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley | 1993 |
Endogenous synthesis of endothelin-1 may mediate a delayed pressor response after injection of endothelin-1 in rats.
Topics: Alanine; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Enalaprilat; Endothelin Receptor Antagonists; Endothelins; Fatty Acids, Unsaturated; Glycopeptides; Hydrazines; Injections, Intravenous; Male; Peptides, Cyclic; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane | 1995 |
Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure.
Topics: Alanine; Animals; Base Sequence; Heart Failure; Kidney; Lung; Male; Molecular Sequence Data; Neprilysin; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1995 |
Repression of angiotensin II and potentiation of bradykinin contribute to the synergistic effects of dual metalloprotease inhibition in heart failure.
Topics: Alanine; Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Blood Volume; Bradykinin; Cricetinae; Drug Synergism; Enalaprilat; Heart Failure; Irbesartan; Male; Neprilysin; Tetrazoles; Vasodilation; Ventricular Function, Left | 1995 |
Sodium loads enhance the natriuretic responses to atrial natriuretic peptide and neutral endopeptidase inhibitors in conscious cynomolgus monkeys.
Topics: Administration, Oral; Alanine; Animals; Atrial Natriuretic Factor; Dose-Response Relationship, Drug; Endopeptidases; Female; Injections, Intravenous; Macaca fascicularis; Natriuretic Agents; Renal Circulation; Sodium, Dietary | 1994 |
Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
Topics: Alanine; Anesthesia; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Cyclic GMP; Dogs; Drug Synergism; Female; Kidney; Male; Natriuresis; Neprilysin; Renal Circulation; Vascular Resistance; Vasodilation | 1994 |
Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.
Topics: Alanine; Animals; Atrial Natriuretic Factor; Cardiac Pacing, Artificial; Cyclic GMP; Dogs; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Kidney; Male; Natriuresis; Neprilysin; Protease Inhibitors; Urine | 1993 |
Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomyopathies; Cricetinae; Drug Synergism; Enalaprilat; Hemodynamics; Kidney; Male; Neprilysin | 1993 |
Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Captopril; Cardiac Pacing, Artificial; Cyclic GMP; Dogs; Female; Heart Failure; Hemodynamics; Kidney; Male; Neprilysin; Renin | 1993 |
Metabolism of endothelin-1 and big endothelin-1 by recombinant neutral endopeptidase EC.3.4.24.11.
Topics: Alanine; Chromatography, High Pressure Liquid; DNA, Complementary; Endothelin-1; Endothelins; Glycopeptides; Humans; In Vitro Techniques; Iodine Radioisotopes; Neprilysin; Protein Precursors; Recombinant Proteins | 1993 |
Hemodynamic effects of acute and chronic treatment with aladotril, a mixed inhibitor of neutral endopeptidase and angiotensin I-converting enzyme, in conscious rats with myocardial infarction.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Heart; Hemodynamics; Male; Myocardial Infarction; Neprilysin; Peptidyl-Dipeptidase A; Protease Inhibitors; Rats; Rats, Wistar | 1995 |
Bradykinin B2 receptor-mediated chronotropic effect of bradykinin in isolated guinea pig atria.
Topics: Adrenergic beta-Agonists; Alanine; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Function; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Enzyme Inhibitors; Guinea Pigs; Heart; Heart Atria; Heart Rate; In Vitro Techniques; Kallidin; Male; Myocardium; Nitric Oxide; Prostaglandins; Receptor, Bradykinin B2; Receptors, Bradykinin; Sensitivity and Specificity | 1995 |
Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Captopril; Female; Humans; Kidney; Macaca fascicularis; Neprilysin; Peptide Fragments | 1996 |
Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
Topics: Alanine; Angiotensin II; Animals; Aorta, Abdominal; Arteriovenous Shunt, Surgical; Atrial Natriuretic Factor; Cyclic GMP; Diuresis; Enzyme Inhibitors; Heart Failure; Hemodynamics; Male; Natriuresis; Neprilysin; Rats; Rats, Wistar; Renin; Vena Cava, Inferior | 1996 |
Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea-pig lung parenchyma.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Endothelin-1; Endothelins; Glycopeptides; Guinea Pigs; Histamine; In Vitro Techniques; Lung; Neprilysin; Protease Inhibitors; Protein Precursors; Thiorphan | 1996 |
Neutral endopeptidase inhibition, a new approach in the exploration of diabetic vasculopathy in rats.
Topics: Alanine; Animals; Blood Pressure; Capillary Permeability; Captopril; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Female; Glycopeptides; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Streptozocin; Thiorphan | 1995 |
Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cyclic GMP; Enzyme Inhibitors; Female; Kidney; Macaca fascicularis; Natriuretic Peptide, C-Type; Neprilysin; Proteins; Sodium | 1996 |
Effect on prolonged inhibition of neutral endopeptidase on cardiac hypertrophy in rats with myocardial infarction.
Topics: Alanine; Animals; Atrial Natriuretic Factor; Cardiomegaly; Enzyme Inhibitors; Ligation; Male; Myocardial Infarction; Neprilysin; Rats; Rats, Wistar | 1996 |
Acute and chronic neutral endopeptidase inhibition and the natriuretic response to acute volume expansion.
Topics: Alanine; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Cyclic GMP; Diuresis; Enzyme Inhibitors; Heart Rate; Hemodynamics; Kidney; Male; Natriuresis; Neprilysin; Rats; Rats, Wistar | 1998 |
Renal effects of 2-mercaptoacetyl-L-leucyl-L-phenylalanine, a novel selective inhibitor of neutral endopeptidase 24.11 (Neprilysin): comparison with SQ 28,603.
Topics: Alanine; Animals; Blood Pressure; Cattle; Dipeptides; Enzyme Inhibitors; Kidney; Male; Neprilysin; Rats; Rats, Wistar; Regional Blood Flow; Renal Circulation; Sodium; Urodynamics; Vascular Resistance | 1999 |